Table 11.
Compound | R1 | R2 | Activity | ||
---|---|---|---|---|---|
Ki 1 (µM) | RF 2 (Daunomycin) | RF 2 (Vimblastine) | |||
100 | OH | OH | 0.28 | 5.6 | 23.7 |
101 | OH | 0.54 | 10.8 | 19.1 | |
102 | OH | 0.13 | 11.8 | 17.4 | |
103 | OH | 1.21 | 11.8 | 11.2 | |
104 | OH | 0.19 | 15.8 | 27.4 | |
105 | OH | 0.63 | 10.0 | 20.6 | |
Verapamil (1) | - | - | 2.8 | 8.7 |
1 Ki—concentration of compounds that inhibits 50% of P-gp-mediated daunomycin transport; 2 RF—Reversal fold: indicate the ability of the tested compounds to reduce resistance of multidrug resistance cells to daunomycin/vinblastine. RF values were calculated by the ratio between IC50 of daunomycin or vinblastine in the absence and in the presence of the tested sesquiterpene derivatives at 1 µM.